December 2020

We’ll no longer cover Cosentyx for commercial members, starting Jan. 1, 2021

Blue Cross Blue Shield of Michigan and Blue Care Network will no longer cover Cosentyx^® for commercial members, starting Jan. 1, 2021, but current Cosentyx authorization for these members is effective until its expiration date or Feb. 28, 2021, whichever comes first. However, members may pay more on or after Jan. 1, 2021.

Members who fill a prescription for Cosentyx on or after March 1, 2021, will be responsible for the full cost.

Taltz^® will be added as a preferred medication, effective Jan. 1, 2021. We’ll cover the following alternatives that have similar effectiveness, quality and safety:

Common use	Preferred alternatives
Ankylosing spondylitis	Taltz, Enbrel^®, Humira^®
Psoriatic arthritis	Taltz, Enbrel, Humira, Otezla^®, Stelara^® SC, Tremfya^®, Xeljanz^®/XR
Psoriasis	Taltz, Enbrel, Humira, Otezla, Skyrizi^®, Stelara SC, Tremfya

We’ll send letters to affected members and their groups, as well as to health care providers, to let them know about this change.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2019 American Medical Association. All rights reserved.